Human genetics professor receives Banting Discovery Award

Sirui Zhou, Assistant Professor in the Department of Human Genetics, has been awarded a prestigious 2025 Banting Discovery Foundation’s Discovery Award. The award program recognizes innovative biomedical health research projects led by outstanding new investigators at universities and research institu

McGill’s President honours outstanding early-career researchers

Three McGill scholars were recognized with the 2025 President’s Prize for Outstanding Emerging Researchers at the Health Sciences Convocation Ceremony on May 27.

The Child Phonology Lab at SCSD is looking for parent participants

Provost honours 31 McGill professors for exceptional research achievements

McGill Cares: Building your team for unplanned life transitions

Join us on May 7th at noon for the next McGill Cares webcast to support informal caregivers. During candid, interviews with leading experts, Claire Webster explores topics related to caring for a loved one with dementia.

AI analysis of healthcare records reveals key factors in autism diagnosis

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

Montreal, March 26, 2025 – McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based therapies for cancer and rare genetic diseases. The awards were initially announced at the D2R Research Symposium on March 13, 2025.

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

A healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub.

Latest Alzheimer’s drug shown less effective in females than males

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.

Genetic sequencing project receives more than $8 million in funding

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of McGill University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Project to create AI model for ALS receives Génome Québec funding

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.

Prescribing anti-swelling drug reduces immune response weeks after last dose

Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.